BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Feng F, Tian Y, Xu G, Liu Z, Liu S, Zheng G, Guo M, Lian X, Fan D, Zhang H. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer. BMC Cancer. 2017;17:737. [PMID: 29121872 DOI: 10.1186/s12885-017-3738-y] [Cited by in Crossref: 48] [Cited by in F6Publishing: 62] [Article Influence: 9.6] [Reference Citation Analysis]
Number Citing Articles
1 Yang TW, Wang CC, Hung WC, Liu YH, Sung WW, Tsai MC. Improvement in the Mortality-to-Incidence Ratios for Gastric Cancer in Developed Countries With High Health Expenditures. Front Public Health 2021;9:713895. [PMID: 34485236 DOI: 10.3389/fpubh.2021.713895] [Reference Citation Analysis]
2 Arrieta O, Varela-Santoyo E, Cardona AF, Sánchez-Reyes R, Lara-Mejía L, Bassarmal SS, Valle-Bautista D, Corrales-Rodríguez L, Motola-Kuba D, Cabrera-Miranda L, Martín C. Association of Carcinoembryonic Antigen Reduction With Progression-free and Overall Survival Improvement in Advanced Non-small-cell Lung Cancer. Clin Lung Cancer 2021:S1525-7304(21)00068-1. [PMID: 33947631 DOI: 10.1016/j.cllc.2021.03.014] [Reference Citation Analysis]
3 Altay SB, Akkurt G, Yılmaz N, Özdemir N. Clinicopathological Evaluation of Gastric Signet Ring Cell Carcinoma: Our Experience. Euroasian J Hepatogastroenterol 2020;10:76-84. [PMID: 33511069 DOI: 10.5005/jp-journals-10018-1325] [Reference Citation Analysis]
4 Jin T. LncRNA DRAIR is a novel prognostic and diagnostic biomarker for gastric cancer. Mamm Genome 2021;32:503-7. [PMID: 34510245 DOI: 10.1007/s00335-021-09911-2] [Reference Citation Analysis]
5 Liu F, Hu HJ, Ma WJ, Yang Q, Wang JK, Li FY. Prognostic significance of neutrophil-lymphocyte ratio and carbohydrate antigen 19-9 in patients with gallbladder carcinoma. Medicine (Baltimore) 2019;98:e14550. [PMID: 30813165 DOI: 10.1097/MD.0000000000014550] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
6 Yang Z, Sun Y, Liu R, Shi Y, Ding S. Plasma long noncoding RNAs PANDAR, FOXD2-AS1, and SMARCC2 as potential novel diagnostic biomarkers for gastric cancer. Cancer Manag Res 2019;11:6175-84. [PMID: 31308753 DOI: 10.2147/CMAR.S201935] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
7 Shen M, Wang H, Wei K, Zhang J, You C. Five common tumor biomarkers and CEA for diagnosing early gastric cancer: A protocol for a network meta-analysis of diagnostic test accuracy. Medicine (Baltimore) 2018;97:e0577. [PMID: 29742692 DOI: 10.1097/MD.0000000000010577] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
8 Chen S, Pan S, Wu H, Zhou J, Huang Y, Wang S, Liu A. ICAM1 Regulates the Development of Gastric Cancer and May Be a Potential Biomarker for the Early Diagnosis and Prognosis of Gastric Cancer. Cancer Manag Res 2020;12:1523-34. [PMID: 32184657 DOI: 10.2147/CMAR.S237443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Suenaga Y, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer. World J Gastrointest Oncol 2019; 11(1): 17-27 [PMID: 30984347 DOI: 10.4251/wjgo.v11.i1.17] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Kambara Y, Miyake H, Nagai H, Yoshioka Y, Shibata K, Asai S, Yuasa N. CA19-9 is a significant prognostic marker of patients with stage III gastric cancer. Eur J Surg Oncol 2020;46:1918-24. [PMID: 32814681 DOI: 10.1016/j.ejso.2020.05.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Lu J, Zhang PY, Xie JW, Wang JB, Lin JX, Chen QY, Cao LL, Li P, Zheng CH, Huang CM. Circular RNA hsa_circ_0006848 Related to Ribosomal Protein L6 Acts as a Novel Biomarker for Early Gastric Cancer. Dis Markers 2019;2019:3863458. [PMID: 31565098 DOI: 10.1155/2019/3863458] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
12 Zhang S, Zhang R, Li RZ, Wang QX, Chang H, Ding PR, Li LR, Wu XJ, Chen G, Zeng ZF, Xiao WW, Gao YH. Beneficiaries of radical surgery among clinical complete responders to neoadjuvant chemoradiotherapy in rectal cancer. Cancer Sci 2021;112:3607-15. [PMID: 34146368 DOI: 10.1111/cas.15039] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Huang H, Wu K, Chen L, Lin X. Study on the Application of Systemic Inflammation Response Index and Platelet-Lymphocyte Ratio in Ovarian Malignant Tumors. Int J Gen Med 2021;14:10015-22. [PMID: 34955651 DOI: 10.2147/IJGM.S346610] [Reference Citation Analysis]
14 Wang X, Li C, Fang M, Zhang L, Zhong L, Dong D, Tian J, Shan X. Integrating No.3 lymph nodes and primary tumor radiomics to predict lymph node metastasis in T1-2 gastric cancer. BMC Med Imaging 2021;21:58. [PMID: 33757460 DOI: 10.1186/s12880-021-00587-3] [Reference Citation Analysis]
15 Iwasaki H, Shimura T, Yamada T, Okuda Y, Natsume M, Kitagawa M, Horike SI, Kataoka H. A novel urinary microRNA biomarker panel for detecting gastric cancer. J Gastroenterol. 2019;54:1061-1069. [PMID: 31240436 DOI: 10.1007/s00535-019-01601-w] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
16 Fang T, Wang H, Wang Y, Lin X, Cui Y, Wang Z. Clinical Significance of Preoperative Serum CEA, CA125, and CA19-9 Levels in Predicting the Resectability of Cholangiocarcinoma. Dis Markers. 2019;2019:6016931. [PMID: 30863466 DOI: 10.1155/2019/6016931] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
17 Xue W, Xu X, Tan Y, Wang Y, Wang H, Xu Y, Xi C, Jiang P, Ding W. Evaluation and validation of the prognostic value of nutrition and immunity parameters in gastric cancer after R0 resection. Medicine (Baltimore) 2020;99:e19270. [PMID: 32080137 DOI: 10.1097/MD.0000000000019270] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
18 Guo YY, Peng XL, Zhan N, Tian S, Li J, Dong WG. Development and validation a simple model for identify malignant ascites. Int J Med Sci 2021;18:1966-74. [PMID: 33850466 DOI: 10.7150/ijms.53743] [Reference Citation Analysis]
19 Wu J, Hu S, Zhang L, Xin J, Sun C, Wang L, Ding K, Wang B. Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis. Theranostics 2020;10:4544-56. [PMID: 32292514 DOI: 10.7150/thno.40532] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
20 Xu W, Ma Q, Wang L, He C, Lu S, Ni Z, Hua Z, Zhu Z, Yang Z, Zheng Y, Feng R, Yan C, Li C, Yao X, Chen M, Liu W, Yan M, Zhu Z. Prediction Model of Tumor Regression Grade for Advanced Gastric Cancer After Preoperative Chemotherapy. Front Oncol 2021;11:607640. [PMID: 33937020 DOI: 10.3389/fonc.2021.607640] [Reference Citation Analysis]
21 Kanda M, Suh YS, Park DJ, Tanaka C, Ahn SH, Kong SH, Lee HJ, Kobayashi D, Fujiwara M, Shimada H, Cho B, Murotani K, Kim HH, Yang HK, Kodera Y. Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational study. Gastric Cancer 2020;23:203-11. [PMID: 31377880 DOI: 10.1007/s10120-019-00995-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
22 Yin XY, Pang T, Liu Y, Cui HT, Luo TH, Lu ZM, Xue XC, Fang GE. Development and validation of a nomogram for preoperative prediction of lymph node metastasis in early gastric cancer. World J Surg Oncol 2020;18:2. [PMID: 31898548 DOI: 10.1186/s12957-019-1778-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Tong Y, Zhao Y, Shan Z, Zhang J. CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy. BMC Cancer 2021;21:4. [PMID: 33402124 DOI: 10.1186/s12885-020-07666-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Kotzev AI, Draganov PV. Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 72-4 in Gastric Cancer: Is the Old Band Still Playing? Gastrointest Tumors. 2018;5:1-13. [PMID: 30574476 DOI: 10.1159/000488240] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
25 Koper-Lenkiewicz OM, Kamińska J, Gawrońska B, Matowicka-Karna J. The role and diagnostic potential of gastrokine 1 in gastric cancer. Cancer Manag Res 2019;11:1921-31. [PMID: 30881118 DOI: 10.2147/CMAR.S194949] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
26 Chen H, Huang Z, Sun B, Wang A, Wang Y, Shi H, Zheng T, Li T, Huang M, Fu W. The predictive value of systemic immune inflammation index for postoperative survival of gallbladder carcinoma patients. J Surg Oncol 2021;124:59-66. [PMID: 33765331 DOI: 10.1002/jso.26470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Wu X, Wang Q, Lu Y, Zhang J, Yin H, Yi Y. Clinical application of thioredoxin reductase as a novel biomarker in liver cancer. Sci Rep 2021;11:6069. [PMID: 33727662 DOI: 10.1038/s41598-021-85688-3] [Reference Citation Analysis]
28 Peng W, Zhou Z, Zhong Y, Sun Y, Wang Y, Zhu Z, Jiao W, Bai M, Sun J, Lu J, Yin H. Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer. Sci Rep 2019;9:19084. [PMID: 31836775 DOI: 10.1038/s41598-019-55641-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
29 Su C, Li H, Peng Z, Ke D, Fu H, Zheng X. Identification of plasma RGS18 and PPBP mRNAs as potential biomarkers for gastric cancer using transcriptome arrays. Oncol Lett 2019;17:247-55. [PMID: 30655761 DOI: 10.3892/ol.2018.9608] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Wang S, Qin J, Ye H, Wang K, Shi J, Ma Y, Duan Y, Song C, Wang X, Dai L, Wang K, Wang P, Zhang J. Using a panel of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of gastric cancer. Oncoimmunology 2018;7:e1452582. [PMID: 30221047 DOI: 10.1080/2162402X.2018.1452582] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
31 Jia W, Zhang J, Ma F, Hao S, Li X, Guo R, Gao Q, Sun Y, Jia J, Li W. Long noncoding RNA THAP9-AS1 is induced by Helicobacter pylori and promotes cell growth and migration of gastric cancer. Onco Targets Ther 2019;12:6653-63. [PMID: 32021238 DOI: 10.2147/OTT.S201832] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
32 Chen J, Liu Z, Gao G, Mo Y, Zhou H, Huang W, Wu L, He X, Ding J, Luo C, Long H, Feng J, Sun Y, Guan X. Efficacy of circulating microRNA-130b and blood routine parameters in the early diagnosis of gastric cancer. Oncol Lett 2021;22:725. [PMID: 34429765 DOI: 10.3892/ol.2021.12986] [Reference Citation Analysis]
33 de Oliveira TM, de Lacerda JTJG, Leite GGF, Dias M, Mendes MA, Kassab P, E Silva CGS, Juliano MA, Forones NM. Label-free peptide quantification coupled with in silico mapping of proteases for identification of potential serum biomarkers in gastric adenocarcinoma patients. Clin Biochem 2020;79:61-9. [PMID: 32097616 DOI: 10.1016/j.clinbiochem.2020.02.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Chen YY, Feng Y, Mao QS, Ma P, Liu JZ, Lu W, Liu YF, Chen X, Hu YL, Xue WJ. Diagnostic and prognostic value of the peripheral natural killer cell levels in gastric cancer. Exp Ther Med 2020;20:3816-22. [PMID: 32855731 DOI: 10.3892/etm.2020.9101] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Yu L, Lai Q, Feng Q, Li Y, Feng J, Xu B. Serum Metabolic Profiling Analysis of Chronic Gastritis and Gastric Cancer by Untargeted Metabolomics. Front Oncol 2021;11:636917. [PMID: 33777793 DOI: 10.3389/fonc.2021.636917] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Song XH, Liu K, Yang SJ, Zhang WH, Chen XL, Zhao LY, Chen XZ, Yang K, Zhou ZG, Hu JK. Prognostic Value of Changes in Preoperative and Postoperative Serum CA19-9 Levels in Gastric Cancer. Front Oncol 2020;10:1432. [PMID: 33014781 DOI: 10.3389/fonc.2020.01432] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Hashimoto K, Inada M, Yamamoto Y, Ochiya T. Preliminary evaluation of miR-1307-3p in human serum for detection of 13 types of solid cancer using microRNA chip. Heliyon 2021;7:e07919. [PMID: 34541347 DOI: 10.1016/j.heliyon.2021.e07919] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 de Mello RA, Amaral GA, Neves NM, Lippo EG, Parini F, Xu S, Tolia M, Charalampakis N, Tadokoro H, Castelo-Branco P, Zhu J. Current and potential biomarkers in gastric cancer: a critical review of the literature. Future Oncol 2021;17:3383-96. [PMID: 34291647 DOI: 10.2217/fon-2021-0084] [Reference Citation Analysis]
39 Chen J, Wu L, Sun Y, Luo C, Chen X, Wu L, Ding J, Pan G, Han C, Wu Z, Shen Y. Diagnostic value and clinical significance of circulating miR-650 and CA211 in detecting of gastric carcinoma. Oncol Lett 2020;20:254. [PMID: 32994817 DOI: 10.3892/ol.2020.12117] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Liu L, Pang H, He Q, Pan B, Sun X, Shan J, Wu L, Wu K, Yao X, Guo Y. A novel strategy to identify candidate diagnostic and prognostic biomarkers for gastric cancer. Cancer Cell Int 2021;21:335. [PMID: 34215253 DOI: 10.1186/s12935-021-02007-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Jiang Y, Tang Y, Miao P. Polydopamine nanosphere@silver nanoclusters for fluorescence detection of multiplex tumor markers. Nanoscale 2019;11:8119-23. [DOI: 10.1039/c9nr01307e] [Cited by in Crossref: 34] [Cited by in F6Publishing: 7] [Article Influence: 11.3] [Reference Citation Analysis]
42 Li J, Xu L, Run ZC, Feng W, Liu W, Zhang PJ, Li Z. Multiple cytokine profiling in serum for early detection of gastric cancer. World J Gastroenterol 2018; 24(21): 2269-2278 [PMID: 29881236 DOI: 10.3748/wjg.v24.i21.2269] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
43 Cui C, Duan Y, Qiu C, Wang P, Sun G, Ye H, Dai L, Han Z, Song C, Wang K, Shi J, Zhang J. Identification of Novel Autoantibodies Based on the Human Proteomic Chips and Evaluation of Their Performance in the Detection of Gastric Cancer. Front Oncol 2021;11:637871. [PMID: 33718231 DOI: 10.3389/fonc.2021.637871] [Reference Citation Analysis]
44 Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. Int J Mol Sci. 2020;21. [PMID: 32512697 DOI: 10.3390/ijms21114012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 18.5] [Reference Citation Analysis]
45 Wang XQ, Zheng Y, Fang PF, Song XB. Nesfatin-1 is a potential diagnostic biomarker for gastric cancer. Oncol Lett 2020;19:1577-83. [PMID: 31966083 DOI: 10.3892/ol.2019.11200] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
46 Zhang M, Ding C, Xu L, Feng S, Ling Y, Guo J, Liang Y, Zhou Z, Chen Y, Qiu H. A nomogram to predict risk of lymph node metastasis in early gastric cancer. Sci Rep 2021;11:22873. [PMID: 34819570 DOI: 10.1038/s41598-021-02305-z] [Reference Citation Analysis]
47 Li C, Li J, Xu Y, Zhan Y, Li Y, Song T, Zheng J, Yang H. Application of Phage-Displayed Peptides in Tumor Imaging Diagnosis and Targeting Therapy. Int J Pept Res Ther 2020;:1-9. [PMID: 32901205 DOI: 10.1007/s10989-020-10108-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Xue W, Xu X, Tan Y, Qian Y, Wang H, Wang Y, Xu Y, Zhu X, Jiang P, Ding W. Evaluating and validating the predictive ability of preoperative systemic inflammatory/immune cells in gastric cancer following R0 resection. Oncol Lett 2019;18:5205-14. [PMID: 31612031 DOI: 10.3892/ol.2019.10867] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Ge S, Wang S, Xiang W, Wang L, Zhu Y, Zhu X, Wang X, Zuo L, Jiang C, Li S, Liu M. [Association of adenylate cyclase-associated protein 2 expression with histopathology and long-term prognosis of gastric cancer]. Nan Fang Yi Ke Da Xue Xue Bao 2019;39:1052-8. [PMID: 31640951 DOI: 10.12122/j.issn.1673-4254.2019.09.08] [Reference Citation Analysis]
50 Yu Q, Li KZ, Fu YJ, Tang Y, Liang XQ, Liang ZQ, Bai JH. Clinical significance and prognostic value of C-reactive protein/albumin ratio in gastric cancer. Ann Surg Treat Res 2021;100:338-46. [PMID: 34136430 DOI: 10.4174/astr.2021.100.6.338] [Reference Citation Analysis]
51 Wang B, Xie Y, Zheng L, Zheng X, Gao J, Liu X, Yuan Y, Li Z, Lu N, Xue L. Both the serum AFP test and AFP/GPC3/SALL4 immunohistochemistry are beneficial for predicting the prognosis of gastric adenocarcinoma. BMC Gastroenterol 2021;21:408. [PMID: 34706681 DOI: 10.1186/s12876-021-01986-0] [Reference Citation Analysis]
52 Li G, Wang G, Chi F, Jia Y, Wang X, Mu Q, Qin K, Zhu X, Pang J, Xu B, Feng G, Niu Y, Gong T, Zhang H, Dong X, Liu T, Ma J, Gao Z, Tao K, Li F, Xu J, Yu B. Higher postoperative plasma EV PD-L1 predicts poor survival in patients with gastric cancer. J Immunother Cancer 2021;9:e002218. [PMID: 33753568 DOI: 10.1136/jitc-2020-002218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Chao C, Sang C, Wang M, Wang Z, Li Y, Luo G, Zhang X. Prognostic significance of microRNA-135 in patients with digestive system cancers: a systematic review and meta-analysis. Biosci Rep 2019;39:BSR20190845. [PMID: 31803920 DOI: 10.1042/BSR20190845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
54 Li X, Zheng NR, Wang LH, Li ZW, Liu ZC, Fan H, Wang Y, Dai J, Ni XT, Wei X, Liu MW, Li K, Li ZX, Zhou T, Zhang Y, Zhang JY, Kadeerhan G, Huang S, Wu WH, Liu WD, Wu XZ, Zhang LF, Xu JM, Gerhard M, You WC, Pan KF, Li WQ, Qin J. Proteomic profiling identifies signatures associated with progression of precancerous gastric lesions and risk of early gastric cancer. EBioMedicine 2021;74:103714. [PMID: 34818622 DOI: 10.1016/j.ebiom.2021.103714] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Hu Z, Tan S, Chen S, Qin S, Chen H, Qin S, Huang Z, Zhou F, Qin X. Diagnostic value of hematological parameters platelet to lymphocyte ratio and hemoglobin to platelet ratio in patients with colon cancer. Clin Chim Acta 2020;501:48-52. [PMID: 31809747 DOI: 10.1016/j.cca.2019.11.036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
56 Lin L, Mi Y, Li X, Peng C, Shangguan Z, Li Z, Liu S. Higher plasma concentration of TP53-induced glycolysis and apoptosis regulator is associated with a lower risk of colorectal cancer metastasis. Cancer Manag Res 2019;11:263-72. [PMID: 30636898 DOI: 10.2147/CMAR.S190272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
57 Kusumoto H, Tashiro K, Shimaoka S, Tsukasa K, Baba Y, Furukawa S, Furukawa J, Niihara T, Hirotsu T, Uozumi T. Efficiency of Gastrointestinal Cancer Detection by Nematode-NOSE (N-NOSE). In Vivo 2020;34:73-80. [PMID: 31882465 DOI: 10.21873/invivo.11747] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
58 Zhang ZG, Xu L, Zhang PJ, Han L. Evaluation of the value of multiparameter combined analysis of serum markers in the early diagnosis of gastric cancer. World J Gastrointest Oncol 2020; 12(4): 483-491 [PMID: 32368325 DOI: 10.4251/wjgo.v12.i4.483] [Cited by in CrossRef: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Necula L, Matei L, Dragu D, Neagu AI, Mambet C, Nedeianu S, Bleotu C, Diaconu CC, Chivu-Economescu M. Recent advances in gastric cancer early diagnosis. World J Gastroenterol 2019; 25(17): 2029-2044 [PMID: 31114131 DOI: 10.3748/wjg.v25.i17.2029] [Cited by in CrossRef: 76] [Cited by in F6Publishing: 70] [Article Influence: 25.3] [Reference Citation Analysis]
60 Zhang M, Zhang Y, Fu J, Zhang L. Serum CA125 levels are decreased in rectal cancer but increased in fibrosis-associated diseases and in most types of cancers. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A. Elsevier; 2019. pp. 241-52. [DOI: 10.1016/bs.pmbts.2018.12.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
61 Huang G, Chen R, Lu N, Chen Q, Lv W, Li B. Combined Evaluation of Preoperative Serum CEA and CA125 as an Independent Prognostic Biomarker in Patients with Early-Stage Cervical Adenocarcinoma. Onco Targets Ther 2020;13:5155-64. [PMID: 32606736 DOI: 10.2147/OTT.S250614] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
62 Wang Z, Mo TM, Tian L, Chen JQ. Gastrin-17 Combined with CEA, CA12-5 and CA19-9 Improves the Sensitivity for the Diagnosis of Gastric Cancer. Int J Gen Med 2021;14:8087-95. [PMID: 34795515 DOI: 10.2147/IJGM.S335985] [Reference Citation Analysis]
63 Zhang W, Yang Z, Gao X, Wu Q. Advances in the discovery of novel biomarkers for cancer: spotlight on protein N-glycosylation. Biomark Med 2020;14:1031-45. [PMID: 32940073 DOI: 10.2217/bmm-2020-0185] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
64 Leja M, Linē A. Early detection of gastric cancer beyond endoscopy - new methods. Best Pract Res Clin Gastroenterol 2021;50-51:101731. [PMID: 33975677 DOI: 10.1016/j.bpg.2021.101731] [Reference Citation Analysis]
65 Zhong Y, Fan Q, Zhou Z, Wang Y, He K, Lu J. Plasma cfDNA as a Potential Biomarker to Evaluate the Efficacy of Chemotherapy in Gastric Cancer. Cancer Manag Res 2020;12:3099-106. [PMID: 32440208 DOI: 10.2147/CMAR.S243320] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Zhang J, Ruan J, Wang W, Lu Y, Wang H, Yu X, Wang H, Teng L. Prognostic Value of the Combination of CEA and Fibrinogen/Albumin Ratio in Resectable Gastric Cancer. Cancer Manag Res 2020;12:2767-75. [PMID: 32368151 DOI: 10.2147/CMAR.S246566] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
67 Herrera-Pariente C, Montori S, Llach J, Bofill A, Albeniz E, Moreira L. Biomarkers for Gastric Cancer Screening and Early Diagnosis. Biomedicines 2021;9:1448. [PMID: 34680565 DOI: 10.3390/biomedicines9101448] [Reference Citation Analysis]
68 Fang T, Wang Y, Yin X, Zhai Z, Zhang Y, Yang Y, You Q, Li Z, Ma Y, Li C, Song H, Shi H, Zhang Y, Yu X, Gao H, Sun Y, Xie R, Xue Y. Diagnostic Sensitivity of NLR and PLR in Early Diagnosis of Gastric Cancer. J Immunol Res. 2020;2020:9146042. [PMID: 32211444 DOI: 10.1155/2020/9146042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
69 Xie MZ, Tang YP, Hu BL, Li KZ, Li JL, Liang XQ. Percentage of Natural Killer (NK) Cells in Peripheral Blood Is Associated with Prognosis in Patients with Gastric Cancer: A Retrospective Study from a Single Center. Med Sci Monit 2021;27:e927464. [PMID: 33500378 DOI: 10.12659/MSM.927464] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]